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The Challenges of Consulting the Public on Science Policy: Examining the development 
of European risk assessment policy for genetically modified animals 
 
Abstract  
With the growing importance of public engagement in science policy-making and declining 
levels of public trust in food production, the European Food Safety Authority (EFSA) has 
attempted to embed ‘good governance’ approaches to strengthen scientific independence and 
open-up risk decision-making, which include the use of public consultations. However 
‘opening-up’ of risk assessment policies reveals some tensions, namely: balancing the goals 
of scientific excellence and transparency; protecting science from interests; addressing value 
judgments; limited opportunities to debate ethical and social issues. EFSA’s development of 
risk assessment policy for genetically modified animals is used as a case study to analyse 
these tensions. This analysis suggests that in order to fulfil good governance commitments 
and maintain trust in risk governance closer cooperation between EFSA and the European 
Commission is required to provide ‘space’ for debating the broader risk management issues. 
This publically-accessible space may be needed alongside rather than instead of EFSA’s 
consultation. 
1. Introduction 
With the growing importance of public engagement in science policy-making and declining 
levels of public trust in food production, the European Food Safety Authority (EFSA) has 
attempted to strengthen scientific independence and open-up risk decision-making through 
the use of public consultations. However ‘opening-up’ risk assessment policies reveals some 
tensions, namely: balancing the goals of scientific excellence and transparency; protecting 
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science from interests; addressing value judgments; and limited opportunities to debate 
ethical and social issues.  
The role of publics in the development of science policy has shifted considerably in the last 
twenty years, from one where publics are deemed to have a deficit in knowledge or 
understanding and as such need education about science, to one in which publics are valuable 
contributors to science policy development (Burgess, 2014; Jones, 2014). In response to this 
shift in thinking about the role of publics and the democratic deficit resulting from various 
food and agricultural crises that were seen in Europe in the 1990s, the European Commission 
(‘Commission’) initiated a new ‘good governance’ agenda that involved opening-up science 
policy-making to the public. At the turn of the century, the Commission’s White Paper on 
European Governance set out an agenda to increase legitimacy and rebuild trust in expert 
advice and European governing institutions more broadly, including those with risk 
assessment and management responsibilities (European Commission, 2001). An outcome of 
this White Paper was the General Food Law Regulation (EC Regulation No 178, 2002) which 
established EFSA in 2002 to provide scientific advice to the Commission on food safety 
matters and take responsibility for the risk assessment1 and communication functions of risk 
analysis. Since its establishment, EFSA has played a significant role in developing European 
risk assessment policy2 through its ‘Guidance‘ documents which explain the principles 
behind the procedures and approaches to risk assessment and specify the information and 
data required for risk assessors, risk managers and applicants (Vos & Wendler, 2006). EFSA 
embedded this notion of good governance with a specific focus on strengthening the 
independence of scientific advice and opening-up risk assessment policy to the public 
through consultations.  
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Traditionally, decisions concerning risk assessment policy have been left to scientific experts 
with the public participation literature suggesting public consultations are more appropriate 
for risk management decisions than for risk assessments policy (Rowe & Frewer, 2000). In 
this context, EFSA’s public consultations should be recognised as innovative. However, 
opening-up a scientific body to public involvement has resulted in greater levels of scrutiny 
and in turn has triggered debate about a number of possible tensions in the food risk 
characterisation and management process at a policy-level. Through an analysis of the 
published literature, this work identifies four tensions arising from opening-up science policy, 
particularly risk assessment policy to public or stakeholder involvement:  
1] A tension is observed between the goals of scientific excellence and openness and 
transparency, particularly when public consultations are used to achieve both goals. 
Opening up science policy-making to public and stakeholder involvement brings a broader 
range of knowledge that may challenge traditional notions of scientific excellence and 
expertise, potentially allowing values to shape scientific outputs and therefore undermine 
these notions of scientific excellence (Scientific Committee on Health and Environmental 
Risks, Scientific Committee on Emerging and Newly Identified Health Risks, and Scientific 
Committee on Consumer Safety, 2013; Klintman & Kronsell, 2010; Bengtsson & Klintman, 
2010; Steffek & Ferretti, 2009; Oels, 2006, Waterton & Wynne, 2004). Current management 
approaches limit the ‘opening up’ of policy-making, favouring scientific excellence over a 
broader inclusiveness and therefore such processes are not responsive to public and 
stakeholder expectations.  
2] When endeavouring to ensure that scientific advice in policy processes is at the cutting 
edge of knowledge advances and technology development, yet is independent and protected 
from interests, particularly single issue interests, tensions emerge. Opening up science policy 
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to public and stakeholder input can challenge the independence of scientific advice 
(Klintman & Kronsell, 2010). Management approaches that strive to open-up the process but 
only facilitate technological input and not insights from other stakeholders can be subject to 
criticism regarding access bias and independence.  EFSA has recently been criticised for such 
conflicts, which are more apparent as the organisation strives to open-up. 
3] The tension between acknowledging value judgements in risk assessment that can be 
challenged and traditional notions of science as a value-free enterprise can be difficult to 
manage in an open consultation process and can result in even the very framing of any risk 
assessment being challenged (Begley, 2013; Boyd, 2013; Wickson & Wynne, 2012; Finardi, 
Pellegrini & Rowe, 2012; Fanelli, 2012, 2009; Meghani, 2009; Klintman & Kronsell, 2010; 
Wandall, 2004; National Research Council, 1996; Kunreuther & Slovic, 1996; Brunk, 
Haworth & Lee, 1992). EFSA has at times denied the existence of values in risk assessment 
and management approaches have limited opportunities to discuss them. 
4] The tension between what is deemed as the scientific characterisation of a risk (science) 
and then how that risk ought to be managed (ethics, politics, etc.) in the broader risk 
governance framework can be seen to be controversial and contested. This is often set out in 
statutory terms as the division between risk assessment and risk management. When 
scientific risk assessment policy is developed in isolation from the broader risk management 
policy, a forum to discuss the ethical and social issues associated with risk management 
can be absent and this in turn causes tension (Brunk & Hartley, 2012; Gaskell, Kronberger, 
Fischler, Hampel & Lassen, 2007; Wandall, 2004). Opening-up only part of the risk process 
to a limited public consultation can exacerbate existing frustrations regarding the lack of 
consultation on and consideration of ethical and social dimensions. 
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Despite calls for further research and insights from the social sciences on participation in risk 
assessment policy (Shepherd, 2008), there is a paucity of case-based investigations of public 
consultations employed in the development of risk assessment policy. Here, we analyse the 
four tensions identified above through the illustrative case of EFSA’s development of risk 
assessment policy for genetically modified (GM) animals. EFSA’s establishment has been an 
important step along the ‘good governance’ road for food risk management but some of the 
tensions that are discussed here may impact on the long term legitimacy or perceived 
legitimacy of EFSA’s risk assessment processes not only for GM animals but the governance 
of GM animals in the EU more broadly. This analysis suggests that in order to fulfil good 
governance commitments and maintain trust in risk governance closer cooperation between 
EFSA and the European Commission is required to provide ‘space’ for debating the broader 
risk management issues. This publically-accessible space may be needed alongside rather 
than instead of EFSA’s consultation. The study provides useful insights for future policy 
development at EFSA and holds valuable lessons for wider efforts to consult the public on 
science policy.  
The case of GM animals was selected on the grounds that it is a recent example of EFSA’s 
risk assessment policy, announced in May 2013 and, given the controversy around risk 
governance decisions for animal cloning (Brunk & Hartley, 2012), GM animal policy was 
likely to involve important governance and ethical issues, particularly concerning animal 
welfare. Further, this case allowed access to the data from the public consultations through 
publically accessible documents on EFSA’s website (accessed between May 2013 and March 
2014). Research was conducted through documentary analysis of the resources listed in Table 
1, including EFSA’s corporate and policy documents, meeting minutes, guidance documents 
and open access ‘comments’ submitted through the public consultation processes.  
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Table 1. Documentary analysis: Key documents analysed 
Year Author Document 
2013 EFSA Guidance on the Environmental Risk Assessment of Genetically Modified Animals, Scientific Opinion, 
http://www.efsa.europa.eu/en/efsajournal/doc/3200.pdf   
2013 EFSA Outcome of the Public Consultation on the Draft Scientific Opinion of the Scientific Panel on Genetically 
Modified Organisms Providing Guidance on the Environmental Risk Assessment of Genetically Modified 
Animals, http://www.efsa.europa.eu/en/supporting/doc/428e.pdf  
2012 EFSA  Guidance on the Risk Assessment of Food and Feed from Genetically Modified Animals and on Animal Health 
and Welfare Aspects, http://www.efsa.europa.eu/en/efsajournal/doc/2501.pdf  
2012 EFSA  Outcome of the public consultation on the Draft Scientific Opinion of the Scientific Panels on Genetically 
Modified Organisms and on Animal Health and Welfare on the Guidance on the Risk Assessment of Food and 
Feed from Genetically Modified Animals and on Animal Health and Welfare Aspects, 
http://www.efsa.europa.eu/en/supporting/doc/226e.pdf  
2012 EFSA Draft Guidance on the Environmental Risk Assessment of Genetically Modified Animals, 
http://www.efsa.europa.eu/en/consultationsclosed/call/120621.pdf 
2011 EFSA Draft Guidance on the risk assessment of food and feed from genetically modified animals including animal 
health and welfare aspects,http://www.efsa.europa.eu/en/consultationsclosed/call/110810.pdf   
2011 EFSA  EFSA GMO Unit Report of the GM mammals and birds workshop, 29 October 2010, 
http://www.efsa.europa.eu/en/search/doc/149e.pdf 
2010 EFSA  EFSA GMO Unit Report of the GM fish workshop, 4 February 2010, 
http://www.efsa.europa.eu/en/search/doc/150e.pdf 
2010-
2013 
EFSA Working 
Groups, GMO  
and AHAW 
Panels 
Minutes of meetings 
http://www.efsa.europa.eu/en/gmo/gmowgs.htm  
http://www.efsa.europa.eu/en/panels/gmo.htm  
http://www.efsa.europa.eu/en/panels/ahaw.htm  
Various EFSA Key corporate/policy documents, http://www.efsa.europa.eu/en/aboutefsa/keydocs.htm  
 
 
The following section (Section 2) introduces the case of risk assessment policy development 
for GM animals, briefly laying out the policy process and the public consultations. Section 3 
examines each of the four tensions in the case of EFSA’s development of a risk assessment 
policy for GM animals. Lastly, Section 4 concludes that while EFSA’s public consultation 
policy tool presents a valuable and innovative opportunity to debate the values embedded in 
risk assessment in a way that can strengthen risk governance, it does not appear fit for 
purpose as it limits the type of knowledge that inform risk assessment, is out of step with 
public understandings of risk and the open governance agenda. Closer cooperation between 
EFSA and the Commission on public consultation is required to allow the European public to 
provide input on the full range of issues related to risk governance of GM animals alongside 
EFSA’s public consultation on the scientific aspects of risk governance. 
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2. The case study  
The use of GM animals in open field trials and the marketing and consumption of GM 
animals are governed by Directive 2001/18/EC and Regulation (EC) No 1829/2003.3 In 2007, 
the Commission instructed EFSA to develop risk assessment policy for potential applicants 
who want to release a GM animal into the European environment. Although no GM animal 
has been approved in Europe, scientific experts predict that the first GM animals approved 
for release in Europe will be GM insects used as integrated pest management tools in 
agricultural production and that these animals could be on the European market by the end of 
this decade (Environment Agency Austria, 2010).4 
EFSA developed two Guidance documents for potential applicants that established the risk 
assessment policy for GM animals. In December 2011, EFSA adopted the ‘Guidance on the 
risk assessment of food and feed from genetically modified animals and on animal health and 
welfare aspects’ (EFSA, 2012c). In 2013, EFSA adopted the ‘Guidance on the environmental 
risk assessment of genetically modified animals’ (EFSA, 2013a). In line with EFSA’s 
policies, the process of developing the two Guidance documents included public 
consultations with the aim to increase the quality and effectiveness of public policy outcomes 
and build public trust by ‘opening up’ risk assessment (EFSA, n.d.). 
In 2008, EFSA triggered the formal process of developing a risk assessment policy for GM 
animals. Figure 1. shows the process of developing the Guidance on the environmental risk 
assessment of genetically modified animals. This process included an open call for 
Scientific/Technical Reports to establish the environmental risk assessment criteria. EFSA’s 
expert Genetically Modified Organisms (GMO) and Animal Health and Welfare (AHAW) 
Panels and various working groups used these reports5, Codex Alimentarius Commission 
guidelines, other relevant background information and the comments garnered through expert 
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workshops formed the information basis for the draft Guidance documents. Subsequently, 
EFSA held public consultations for each of the two Guidance documents.   
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Figure 1. The process of developing the Guidance on the environmental risk assessment 
of genetically modified animals  
2007 
2008 
2009 
2010 
2012 
2013 
2011 
EFSA GMO Panel releases the Draft Guidance for public consultation (21 June-31 Aug) 
GM Fish Working Group reviews 
consultation results 
GM Insects Working Group 
reviews consultation results 
GM Mammals & Birds WG 
reviews consultation results 
EFSA GMO Panel 
Guidance Document on the Environmental Risk Assessment of Genetically Modified Animals published (May) 
GM Fish Working Group writes 
Fish section of Guidance 
 
GM Insects Working Group writes 
Insects section of Guidance 
 
GM Mammals & Birds WG writes 
M & B section of Guidance 
 
EFSA GMO Panel 
GM Fish Working Group 
Established 
GM Insects Working Group 
Established 
GM Mammals & Birds Working 
Group Established 
GM Fish Scientific/ Technical 
Report Published (draft: Jan/Feb; 
Final: May) 
GM Insects Scientific/Technical 
Report Published (Final: Sept.) 
GM Mammals & Birds 
Scientific/Technical Report 
Published (draft: Oct; Final: Dec) 
GM Fish Expert Workshop (4th 
Feb) 
GM Mammals & Birds Expert 
Workshop (29th Oct) 
Call for Scientific/Technical 
Report- GM Fish 
Call for Scientific/Technical 
Report- GM Insects 
Call for Scientific/ Technical 
Report- GM Mammals & Birds 
European Commission 
Directive 2001/18/EC and Regulation (EC) No 1829/2003 
EFSA 
The GMO Panel 
Open call for tender: Scientific/Technical Reports to establish risk assessment criteria 
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The first public consultation was held from 10 August to 30 September 2011 on the draft 
‘Guidance on the risk assessment of food and feed from genetically modified animals and on 
animal health and welfare’. The second consultation ran from 12 June to 31 August 2012 on 
the draft ‘Guidance on the environmental risk assessment of genetically modified animals’. 
The public was invited to comment on the draft documents although comments would not be 
taken into account if they related to “policy or risk management aspects, which is out of the 
scope of EFSA's activity” (EFSA, 2012a, p. 10). In the case of the risk assessment of food, 
feed and animal health and welfare, EFSA documents 341 comments from 29 interested 
parties (although it states that it received comments from 32 parties) (EFSA, 2012a). In the 
case of the environmental risk assessment, EFSA received 720 comments from 35 interested 
parties. Tables 2 and 3 document the participants in each of the consultations. These 
interested parties include stakeholders and individual members of the public. EFSA 
considered all comments that fell within its remit. Comments related to the ethical and social 
aspects of the Guidance documents were not addressed (EFSA, 2012a). 
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Table 2. Participants in the public consultation on the environmental risks of GM 
animals  
Environmental risk assessment 
Government department / agency University/ 
research org 
Industry Public interest group Individual  
(1) Advisory Committee on Releases to the 
Environment (GBR) 
(2) Federal Office of Consumer Protection 
and Food Safety (DEU) 
(3) Federal Agency for Nature Conservation 
(DEU) 
(4) Belgian Biosafety Advisory Council (BEL) 
(5) Umweltbundesamt on behalf of Austrian 
Ministry of Health (AUT) 
(6) National Commission on Biosafety (ESP) 
(7) Netherlands Commission on Genetic 
Modification (COGEM) (NDL) 
(8) Ministry of Infrastructure and the 
Environment (NDL) 
(9) Environment Canada (CAN) 
(10) Max-Planck-
Institut für 
Evolutionsbiologie 
(DEU) 
(11) Univ. Perugia 
(ITA) 
(12) University 
Boku (PRT)  
(13) GenØk–
Centre for 
Biosafety (NOR) 
14) Oxitec 
Ltd (GBR) 
(15) GeneWatch UK (GBR) 
(16) Food & Water Europe 
(GBR) 
(17) GM Freeze (GBR) 
(18) Soil Association (GBR) 
(19) TiK (GBR) 
(20) Testbiotech (DEU) 
(21) European Beekeeping 
Coordination (BEL) 
(22) Agernova (ITA) 
(23) Association Soleil en Tête 
(FRA) 
(24) Center for Food Safety  
(USA) 
(25) Friends of the Earth US 
(USA) 
(26) n/a (GBR) 
(27) Self 
Employed (GBR) 
(28) None (GBR) 
(29) Public (GBR) 
(30) Private 
Individual (GBR) 
(31) Personal 
(GBR) 
(32) none  (IRL) 
(33) Individual 
connected (FRA) 
(34) N/A (FRA) 
(35) Self (USA) 
Note: Participants organised by type using names and geographical locations provided by EFSA (2013b).  
Table 3. Participants in the public consultation on the risks from food and feed from 
GM animals and on animal health and welfare  
Risk assessment of food and feed from GM animals and on animal health and welfare 
Government department / 
agency 
University/research 
org 
Industry Public interest group Individual 
(1) Ministry of Rural 
Development of Hungary (HUN) 
(2) Federal Office of Consumer 
Protection and Food Safety 
(DEU) 
(3) Federal Agency for Nature 
Conservation (DEU) 
(4) The Norwegian 
Biotechnology Advisory Board 
(NOR) 
(5) U.S. Food & Drug 
Administration (USA) 
(6) Norwegian Scientific 
Committee for Food Safety 
(NOR) 
(7) Food Standards Agency (GBR) 
(8) French Agency for Food, 
Environmental and Occupational 
Health & Safety (FRA)  
(9) BAC (Scientific Advisory Body 
Secretariat) (BEL) 
(10) University of 
Nebraska Lincoln 
(USA) 
(11) CRIIGEN and 
University of Caen 
(FRA) 
(12) Institute of 
Food Science and 
Technology (GBR) 
(13) European 
Network of 
Scientists for Social 
and Environmental 
Responsibility (DEU) 
(14) BIO (USA) 
(15) European 
Forum of Farm 
Animal Breeders 
and European 
Poultry Breeders 
(BEL) 
(16) Oxitec Ltd 
(GBR) 
 
(17) American Anti-Vivisection 
Society (USA) 
(18) Center for Food Safety  (USA) 
(19) Food & Water Europe (GBR) 
(20) Eurogroup for Animals (BEL) 
(21) Testbiotech/ FOE Europe (DEU) 
(22) Compassion in World Farming 
(GBR) 
(23) Animal Rights Sweden (SWE) 
(24) GeneWatch UK (GBR) 
(25) Irish Doctors'' Environmental 
Association (IRl) 
(26) GM Freeze (GBR) 
(27) France Nature 
Environment/GIET (FRA) 
 
(28) Vet from 
Lockport Animal 
Hospital (USA) 
(29) no (on 
behalf of Food & 
Water Europe) 
(USA) 
 
 
 
 
 
 
Note: Participants organised by type using names and geographical location provided by EFSA (2012a) and a personal communication 
through EFSA’s ‘Ask EFSA’ mechanism (email received 04/03/14).  
In February 2012, EFSA published the final ‘Guidance on the risk assessment of food and 
feed from genetically modified animals and on animal health and welfare’ and in May 2013, 
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it published the final ‘Guidance on the environmental risk assessment of genetically modified 
animals’. Along with each of these documents, EFSA published comments from the public 
consultations on the draft Guidance and explained how these comments had been addressed 
(EFSA, 2012a, 2013b).  
3. Tensions in consulting the public in developing scientific risk assessment policy 
A number of tensions arise from the opening up of the ESFA process through public 
consultation.  In this section, we examine each of the four tensions identified in the literature 
and analyse them for the case of GM animals risk assessment policy development.  
3.1. The tension between the goals scientific excellence and openness and transparency 
EFSA is guided by a set of key values that include scientific excellence and openness and 
transparency (EFSA, 2013d). EFSA defines scientific excellence as “objective and 
independent science-based advice grounded in the most up-to-date and reliable scientific 
information and data available” (EFSA, 2013d, ‘Excellence in science’) and makes a 
structural separation between stakeholders, publics and experts with the explicit goal to 
ensure scientific excellence and independence. At a management level, this distinction can be 
seen between the Stakeholder Consultative Platform6 and the Management Board7 with the 
Stakeholder Consultative Platform consisting of stakeholders and the Management Board 
composed mostly of scientific experts. In the case of the development of a risk assessment 
policy for GM animals, this separation can be seen in the distinction between, on the one 
hand, the public and stakeholders through the public consultations and, on the other hand, 
experts through the GMO and AHAW Panels, expert working groups, and expert workshops.  
Contemporaneous with the pursuit of the goals of scientific excellence, EFSA pursues the 
goal of openness and transparency. Transparency is enshrined in Articles 38 and 39 of 
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EFSA’s Founding Regulation (EC Regulation No 178, 2002) and deemed to allow 
stakeholders and the public to understand the basis for risk assessment, facilitate informed 
debate and promote public confidence in EFSA’s work. EFSA's commitment to openness and 
transparency includes making data accessible to interested parties, opening meetings to 
observers, consulting the public and publishing key documents and minutes from meetings 
(EFSA, 2013d,). In the case of GM animals risk assessment policy, openness and 
transparency includes making available information about experts on the Panels and working 
groups and publishing the minutes of Panel and working group meetings, although the 
minutes of working group meetings do not include information on the substance of the 
meetings. 
Public consultations are a policy tool that EFSA uses to achieve both of these goals, 
increasing scientific excellence in the risk assessment policy and opening-up the process to 
public scrutiny. In EFSA’s approach on Public Consultations on scientific outputs (EFSA, 
n.d.), EFSA states the purpose of the public consultations in relation to the two goals of 
transparency and scientific excellence: “The importance of public consultations to ensure that 
EFSA is seen, and perceived, as a glass house is apparent and inherent to the concept of 
transparency… In addition, consulting on draft scientific outputs are also important in 
gathering views, data sources and comments that should in turn ensure the completeness, the 
clarity and the effective respect of those outputs.” (EFSA, n.d., p. 3). However, the 
consultations present a challenge for EFSA as they explicitly seek input from stakeholders 
and the public, potentially allowing values, particularly through interests, to shape scientific 
outputs and this may if permitted undermine scientific excellence (the specific issue of 
protecting science from interests is addressed in the next section). Therefore, EFSA has to 
find a way to consult the public and stakeholders while ensuring that the evidence provided is 
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scientifically independent if it is to be used in the development of scientific outputs. Further, 
there are two assumptions that underlie this tension. The first assumption is that the balancing 
of scientific excellence, openness and transparency assumes a clear distinction between 
science and values and that it is possible to ensure science is free of values. This assumption 
is addressed in Section 3.3., below. The second assumption is that there is an opportunity to 
address non-scientific issues which fall outside of EFSA’s remit. This assumption is 
addressed in Section 3.4.  
This tension between the goals of scientific excellence, on the one hand, and openness and 
transparency on the other has been well documented (SCHER et al., 2013; Bengtsson & 
Klintman, 2010; Klintman & Kronsell, 2010; Oels, 2006). In 2013, the Commission’s 
Scientific Committees published recommendations on how to improve the relevance of risk 
assessment in Europe (SCHER et al., 2013). The Scientific Committees called for an 
‘opening up’ of risk assessment to include dialogue between risk managers, risk assessors and 
stakeholders. However, since dialogue and interaction between risk managers, risk assessors 
and stakeholders might undermine the independence of science through the influence of 
politics, so far EFSA has kept risk assessment and risk management separated. The Scientific 
Committees are acutely sensitive to this possible critique and throughout their report make it 
clear that risk assessment needs to be maintained as a scientific exercise. As stated, dialogue 
should take place while “ensuring the scientific integrity of the risk assessment” (SCHER et 
al., 2013, p. 8) and that dialogue “should properly inform but not bias what is measured in 
risk assessment” (SCHER et al., 2013, p. 10).  
In the case of EFSA’s development of risk assessment policy for GM animals this tension 
was managed by prioritising the key value of scientific excellence over openness and 
transparency and by prioritising expert knowledge over public and stakeholder knowledge. In 
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this way, openness was constrained and the effectiveness, as well as the legitimacy, of efforts 
to open up risk assessment policy to public input is drawn into question. For example, EFSA 
used experts from the GMO and AHAW Panels and working groups to analyse the public’s 
comments and decide which of these counted as impartial, objective scientific knowledge. 
This approach attributes authority to experts to determine what counts as scientific 
knowledge and a two-tier system develops, privileging expert judgement over the legitimacy 
of public and stakeholder input (Klintman & Kronsell, 2010).  
A good deal of the consultation participants (in Tables 2 and 3, see government 
departments/agencies, university/research organisations, industry and public interest groups) 
contributed scientific arguments and scientific expertise that presented alternative views to 
the EFSA experts as laid out in the draft Guidance documents. These comments often 
disputed the expert determination of what counts as sufficient evidence for risk assessment, 
the type of evidence relied upon and the scientific basis for the comparison of GM animal 
with non-GM surrogates. For example, the Federal Agency for Nature Conservation, a 
government agency, disputed the experts’ determination that experimental data about abiotic 
interactions should only be provided by applicants if it is available, arguing that this data is 
essential for assessing these types of risks. However, in the final Guidance, the expert’s 
determination remained. The dominance of expert knowledge and also the lack of 
opportunity to debate or deliberate on these scientific disputes between experts and 
stakeholders may be seen to undermine the scientific value of consultation.  
Management of the tension between scientific excellence, openness and transparency by 
prioritising selected expert knowledge over public and stakeholder knowledge has been 
identified elsewhere. In a study of the European Environment Agency (EEA), Waterton and 
Wynne (2004) show that while the EEA recognised the value of opening up science policy to 
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new forms of deliberation, to protect its own legitimacy as a science body, it could not 
completely let go of the dominance of scientific knowledge and experts. However, this 
approach may draw into question the effectiveness and legitimacy of efforts to open up risk 
assessment policy to public input. For example, in a report of an EFSA workshop, Gaskell et 
al. (2007) characterised EFSA’s public consultation approach as a ‘sound science’ type of 
public dialogue where EFSA listens to the public but does so in terms of EFSA’s definition of 
the problem and its possible solutions. The externals’ views are heard only in so far as they 
talk in terms of EFSA’s scientific remit and hence this may undermine commitment to the 
outcome of the consultation. 
3.2 Protecting the independence of expert science advice  
An important dynamic that is identified when opening up risk assessment is whether this 
process will create interactions between EFSA Panel members and externals that may be 
deemed as unacceptable access or influence. Many public and private organisations are 
increasingly being scrutinised for potential conflicts of interest. Public regulatory bodies are 
particularly sensitive to these concerns and are striving to embed governance approaches to 
significantly reduce conflicting relationships for staff and appointed members. An analysis 
conducted by Klintman & Kronsell (2010) identifies the potential for science to be shaped 
through interest-driven associations with stakeholders as a dependence that EFSA needs to 
avoid. As part of the implementation of its founding principles EFSA applies two approaches 
to manage interest conflicts, specifically selecting (i) what are defined to be ‘independent 
scientists’ using self-declaration protocols to identify and manage interest conflicts (as do 
other Commission bodies) and (ii) controlled management of the interactions between the 
scientific expert panels and the stakeholder panel. For example, EFSA developed an 
organisational structure which separates panel scientists from members of the Stakeholder 
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Consultative Platform, who unlike the scientists are defined as promoting interests. The need 
to avoid dependence and maintain the integrity of scientific advice is regularly acknowledged 
with independent science being seen as is an ideal that EFSA pursues.  
However, the attainment of independence from interests through structural measures has been 
called into question not only by researchers (Klintman & Kronsell, 2010) but by the EU’s 
own oversight body, the European Court of Auditors (ECA) (European Court of Auditors, 
2012). In a recent ruling the ECA noted that EFSA is one of the EU’s agencies with the 
greatest impartiality risk and that EFSA’s Management Board involvement with external 
experts and partnerships with stakeholders present an inherent conflict of interest risk.  
EFSA has developed several policies to address these risks8 as exemplified by the 2012, 
announcement from EFSA’s Executive Director, Ms. Geslain-Lanéelle (2012) stating EFSA 
had in place a number of measures to assure scientific outputs are based on transparent, open 
and unbiased scientific decision-making processes.9 EFSA describes these mechanisms as 
identifying, assessing and managing conflicts of interest, collective decision-making to 
reduce the influence of single experts, recording minority opinions, inter-disciplinarity and 
multi-disciplinarity of scientific panels and committees, absence of hierarchical links between 
experts, training on conflicts of interest, ethics and integrity and transparency of expert 
meetings and guidance in risk assessment decisions (European Court of Auditors, 2012; 
Geslain-Lanéelle, 2012). In operationalising these principles, one of the mechanisms that 
EFSA still heavily relies upon is the ‘Declaration of Interest’ policies and procedures to 
protect the independence of science. This is managed by experts declaring their relevant 
activities and then these are subsequently screened by EFSA, so that conflicts of interests can 
be assessed and managed. An interest is defined as “all interests falling within fields of 
competence of the Authority” (EFSA, 2012b, p. 4). If a conflict is found, the expert may not 
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be considered for membership or restrictions may be put into place to limit her/his influence 
(Gassin et al., 2012).10  
The effectiveness of EFSA’s ability to ensure the independence of science from the threat of 
interests through ‘Declaration of Interest’ has been questioned in recent years by both EU 
bodies and public interest groups. The recent investigation of conflicts of interests within 
EFSA investigated by the European Court of Auditors (2012),11 the European Parliament 
Committee on Budgetary Control12 (2012) and the European Ombudsman (2013)13 appear to 
highlight significant concerns that the current system may not be fit for purpose.  In addition, 
European pressure groups GeneWatch UK, Testbiotech, Berne Declaration, SwissAid, and 
Corporate Europe Observatory (2012) mounted public campaigns to highlight what they 
perceive to be interest conflict amongst EFSA’s GM animals risk assessment policy experts. 
EFSA asserts that it is possible to obtain independent and objective science through structural 
measures; however the current reliance on a ‘Declarations of Interest’ approach as the 
primary mechanism for protecting scientific outputs from interests appears to be undermined 
by the recent conflicts of interest cases. Work in other sectors highlights the limits of the 
‘Declarations of Interest’ management strategy (Cain & Detsky, 2008; Sismondo, 2008). For 
example, a study by Cain, Loewenstein & Moore (2005, p. 22) found that “disclosure cannot 
be assumed to protect recipients of advice from the dangers posed by conflicts of interest”.. 
For an EU agency with a central role in governance of controversial areas ofn food 
production, embedding, reviewing and revising mechanisms that establish and maintain 
public trust  is paramount. The current approaches for conflict of interest appear to be falling 
short of this and therefore new approaches may be needed. The ‘opening-up’ of the risk 
assessment approach rather than causing the inappropriate introduction of interests may have 
revealed other forms of conflict of interests. Ultimately what this may highlight is that it is 
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not possible in practice to constructively isolate science from interests and therefore new 
approaches may be called for such as innovative forms of ‘opening-up’ that allow interests to 
be transparent and openly debated when policy decisions are taken.   
3.3. Recognising value judgments in risk assessment 
EFSA does not officially recognise that the science used in risk assessment involves value-
based decisions despite a growing body of literature demonstrating the science of risk 
assessment is shaped by implicit values (e.g. Finardi et al., 2012; Wickson & Wynne, 2012; 
Klintman & Kronsell, 2010; Meghani, 2009; Wandall, 2004; Kunreuther & Slovic, 1996; 
National Research Council, 1996; Brunk et al., 1992). It has been argued that it is precisely 
this institutional denial of implicit values that is the cause of the public’s lack of trust in 
science governance (Wynne, 2006). In 2012, Wickson and Wynne (2012) outlined how the 
processes of scientific risk assessment are inevitably shaped by normative commitments and 
argued for addressing this reality “in an enlightened and accountable way” (2012, p. 101). In 
response, a group of authors, representing EFSA’s GMO Panel, did not acknowledge or 
engage with the matter of implicit values, but rather insisted that EFSA’s risk assessment is 
an objective scientific process (and therefore free of values) and risk management (the 
responsibility of the Commission and Member States) is where value choices are made (Perry 
et al., 2012). This position led Wickson and Wynne (2012) to claim that normative choices 
are being made in EU agricultural biotechnology policy under the misrepresented name of 
pure science.  
Implicit values may shape risk assessment through bias, self-interest or research practices 
(Begley, 2013; Fanelli, 2012, 2009). Ian Boyd (2013), Science Advisor for the UK’s 
Department of Environment, Food and Rural Affairs, recently commented in Nature about 
the prevalence of bias and unreliability in scientific research literature, arguing that his role in 
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advising policy-makers is made significantly more challenging by inaccuracies in scientific 
research: with bias rendering the scientific literature ineffective for policy-making. Boyd 
suggests bias may arise from scientists’ tendency to treat different studies as statistically 
independent, not to publish ‘negative’ results and to make statistical inferences, particularly 
when research is conducted on complex issues such as the environmental effects of GMOs. 
He also suggests that bias may be systematic across “whole fields of science” (Boyd, 2013, p. 
159).  
In the case of the risk assessment policy for GM animals, the Guidance documents include 
normative questions, assumptions and commitments which result in values playing a role in 
shaping the risk assessment. Interestingly, in the Guidance on environmental risks, EFSA 
recognises that risk assessment involves subjective judgements, but that these values can be 
managed through uncertainty analysis:  
“In all cases, applicants’ uncertainty analysis should be conducted and presented in a 
reproducible manner … This is particularly important where extensive subjective 
experts’ judgements have been applied. Subjective judgements can introduce 
uncertainty in model structure and parameter values, particularly in data-poor 
situations.” (EFSA, 2013a, p. 43). 
Consultation participants raised concerns about value judgements in the risk assessment 
policy for GM animals. For example, the Norwegian university/research organisation, GenØk 
Centre for Biosafety argued that applicants who wanted to release a GM animal were being 
asked to make explicit value judgements that should be the responsibility of risk managers. In 
particular, it pointed to an instance where applicants were asked to determine the significance 
of harm and acceptability of risk. Nine instances in the Guidance on environmental risk 
assessment for GM animals where applicants are asked to make such a determination are set 
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out in Table 4. EFSA’s Founding Regulation and the European Commission’s Scientific 
Committees clearly state that the determination of acceptable risk is a value-based, risk 
management decision (SCHER et al., 2013). Further, GenØk argued that the problem 
formulation stage of the risk assessment policy involves value decisions about protection 
goals and assessment endpoints that will guide the risk assessment process and therefore this 
stage should be opened up to risk managers and stakeholders (EFSA, 2013b, p. 40). This 
view is echoed by the Commissions Scientific Committees (SCHER et al., 2013). 
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Table 4. Instances where applicants are asked to conclude on levels of acceptable risk 
 Direct quotes from  the ‘Guidance on the environmental risk assessment of GM animals’ 
1 However, it is vital that both the GM and comparator can be reared without unacceptable risk of 
mortality or adverse welfare issues. Care should be taken to choose an experimental design that does 
not suffer unduly from loss of animals during the experiment. (p. 36) 
2 Applicants should describe … why identified environmental impacts are considered acceptable and do 
not present risks. (p. 65; p. 87) 
3 In addition, applicants should explain why identified environmental impacts are considered acceptable 
and do not present risks. (p. 67) 
4 Applicants should conclude on the relative significance and acceptability of any associated 
environmental harm. (p. 69; p. 107) 
5 Risk assessment should determine … (5) why the impacts of the management measures and any 
anticipated or unintended changes to to populations, together with their uncertainty, are considered 
acceptable. (p. 95; p. 104) 
6 Applicants should propose management/mitigation measures to reduce the risks to an acceptable level 
of environmental harm. (p. 106) 
7 It is important that applicants ensure that their risk assessment concludes on all of the following: ... (4) 
why any anticipated harm may be considered acceptable. (p. 121) 
8 Applicants should explain if identified environmental impacts are considered acceptable and do not 
present risks and the reasons thereof. (p. 134) 
9 Applicants should propose appropriate risk management strategies for each risk. These strategies 
should be designed, under assumptions of high exposure scenarios, to reduce the risk to a level 
considered acceptable (criteria defining this acceptability should be explicitly discussed). (p. 153) 
 
EFSA's public consultations present an important opportunity to identify and discuss value 
judgements that are made in the context of risk assessment. Indeed, Finardi et al. (2012) 
argue that it is precisely these implicit value judgements that present the strongest argument 
for EFSA’s public involvement approach. By denying both the existence of values in risk 
assessment and the opportunity to discuss them, EFSA’s values are insulated from criticism 
and debate. Klintman & Kronsell (2010) questioned the underlying purpose of EFSA’s public 
consultations on scientific outputs, suggesting the primary driving force behind the shift 
toward good governance has been to increase public trust through increased legitimacy. 
EFSA has clearly stated that public consultation on “sensitive issues”, such as new 
technologies “is considered essential to encourage the understanding and acceptance of 
EFSA’s scientific work.” (Gaskell et al., 2007, p. 2). The recent instances of institutional 
denial of values in risk assessment and statements like these that suggest that EFSA may see 
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public consultations as best serving its risk communication function rather than its risk 
assessment function appear to be contrary to the good governance agenda that EFSA is 
striving to achieve.   
3.4. Where are ethics and social issues discussed?: The tension between risk assessment and 
risk management  
EFSA’s Founding Regulation makes a clear distinction between the three components of risk 
analysis: assessment, management and communication. EFSA has responsibility for risk 
assessment and communication whereas risk management is the responsibility of the 
European Commission, specifically the Directorate-General for Health and Consumers (DG 
SANCO) and Member States (Gassin, Arcella, Sheye, Ramsay & Kalaïtzis, 2012; Perry et al., 
2012). However, this structural separation of risk assessment from management appears to be 
increasingly at odds with open and accessible governance approaches, particularly when there 
is no notable forum for debate on risk management issues. Further, tensions arise when EFSA 
blurs the lines in practice between risk assessment and management while still embedding a 
distinction in its public consultations. Overall, the absence of a European Commission-led 
forum to debate the social and ethical issues raised by GM animals leads to public and 
stakeholder frustrations with EFSA’s consultation process and risks the legitimacy of EU 
governance of GM animals more broadly. 
In 2007, EFSA held a workshop to investigate consumer perceptions of food products from 
cloned animals. The workshop explored a social scientific approach to risk, particularly the 
social scientific evidence that public perceptions of risk are unlikely to be based on science 
alone, but will also be based on ‘other factors’ that include substantive ethical and procedural 
justice issues, trust, and culture (Gaskell et al., 2007). The report of EFSA’s workshop draws 
attention to two cultures of risk, a science-based one, embraced by EFSA, and a societal one, 
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based on a broader range of considerations. To relieve the tension between the two cultures of 
risk, the EFSA’s workshop report recommends that parallel social dialogues should be held to 
map the broader range of issues: “While retaining the independence of scientific risk 
assessment a social dialogue should map the other factors that are likely to drive public 
perceptions, recognize that consensus across the publics of Europe may not be possible and 
ensure that all decisions are fully justified and the reasons for rejecting certain positions fully 
explained. For EFSA and DG SANCO, the reality and appearance of procedural justice 
should be a priority.” (Gaskell et al., 2007, p. 5).  
EFSA’s workshop on animal cloning was explicitly convened to investigate the risk 
management issues associated with animal cloning, including the ethical and social issues. At 
the time, it was stated that exploring these issues “would help to better understand and 
anticipate societal views and set a context for EFSA’s scientific work.” (Gaskell et al., 2007, 
p. 2). This blurring of the line between risk assessment and management sends a confusing 
message to stakeholders and the public who are not allowed to comment on risk management 
issues in EFSA’s public consultation, even though EFSA itself sees the issues as important 
for setting a context for its work. Indeed, EFSA’s Director of Communications states 
“Experience ... shows that ... ethical considerations must also be taken into consideration and 
that public consultation and stakeholder engagement are critical for informed discussion on 
sensitive technologies.” (Gassin et al., 2012, p. 390).  
EFSA’s Founding Regulation recognises: “scientific risk assessment alone cannot ... provide 
all the information on which a risk management decision should be based, and that other 
factors ... should legitimately be taken into account including societal, economic, traditional, 
ethical and environmental factors.” (EC Regulation No 178, 2002, p. 4). However, it is not 
clear that DG SANCO has created a mechanism at the EU level for debating or understanding 
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these risk management issues related to GM animals. The case of animal cloning for food 
production presents a useful example of what is possible procedurally when developing EU 
governance structures for emerging agricultural technologies. In the case of animal cloning, 
the Commission requested a scientific opinion from EFSA, an ethical opinion from the Group 
of Advisers on the Ethical Implications of Biotechnology (EGE) and a public survey through 
the Eurobarometer. In 2010, the Commission made a decision based on an analysis of these 
three inputs (European Commission, 2010).14 Furthermore, in 2012, the European 
Commission held a public consultation to flush out stakeholder and public views on animal 
cloning for food production, including the economic, social and environmental issues as it 
considered further policy and legislative options for animal cloning for food production 
(European Commission, 2012).  
The Commission requested an ethical opinion on GM animals from the EGE in the early 
1990s. In 1996, the EGE published its Opinion on the Ethical Aspects of Genetic 
Modification of Animals. However, more than twenty years later, this Opinion is out of date 
with technological developments that have taken place in the area of GM animals and 
focused on the use of transgenic methods for the development of experiment animals. In 
addition, this report does not consider GM insects, currently predicted to be the first GM 
animal to pass through the risk assessment process (Environment Agency Austria, 2010), and 
there is no evidence that this document has played a role in the development of the current 
EU governance framework for GM animals. 
Despite the specified terms of reference for EFSA’s public consultations that restricted 
comments to scientific issues, participants addressed the ethical and social issues and 
communicated their frustration about EFSA’s inability to consider these issues. Participants 
raised concerns about procedural legitimacy, including the false separation of science from 
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the ethical and social issues, the lack of space to debate these issues and what was described 
as the premature scientific risk assessment when the social and ethical issues had not been 
debated in the broader policy framework. Some participants saw the consultation as evidence 
of the European Commission’s acceptance that GM animals were desirable without allowing 
for public debate of the full range of issues. Table 5. documents participant concerns about 
procedural legitimacy in the public consultation on Guidance on the risk assessment of food 
and feed from genetically modified animals and on animal health and welfare. However, 
EFSA did not consider these issues as they fell outside its remit “Many comments referred to 
lack of a holistic approach including ethical, political and socioeconomic issues ... These 
comments were considered to be outside the scientific remit of EFSA and were not 
addressed.” (EFSA, 2012a, p. 5). 
Page 27 of 37 
 
Table. 5. Stakeholder concerns about procedural legitimacy 
Quotes from ‘Outcome of the public consultation on the draft scientific opinion of the Scientific Panels on 
GMO and on AHAW on the Guidance on the risk assessment of food and feed from GM animals and on 
animal health and welfare aspects’ (EFSA, 2012a) 
France Nature Environment/GIET  
All online consultations launched by EFSA are in English, which is not the only official language of the EU. This 
is contrary to the Charter of Fundamental Rights … and prevents a large part of European citizens from taking 
part in these online consultations. (p. 25) 
On p.40, the guidance presents several reports and indicators to assess animal welfare. The animal welfare is a 
complex concept that includes scientific, ethical but also economic, cultural and political issues. (p. 74) 
Providing guidance for the risk assessment … implies that general issues, including ethical and socio-economics 
issues, have been previously debated, to decide whether or not genetic modification of animals can be done. 
(p. 25)  
The Norwegian Biotechnology Advisory Board  
When doing risk assessments for genetically modified animals, ethical and socio-economic issues must be 
taken into account in the assessment. Issues concerning ethics, sustainability and benefits to society are just as 
important here as when it comes to GM plants. (p. 26) 
Food & Water Europe  
Risk management and socioeconomic issues are neglected in the discussion of risk assessment for GM animals. 
(p. 16) 
The EFSA (GMO and AHAW) panels … have chosen not to include some of the most important issues 
surrounding GM animals in their risk assessment guidance including risk management issues such as 
traceability, labelling and coexistence, and ethical and socioeconomic issues.  As such, the process is fatally 
flawed. Neglecting to take a look at the full range of issues surrounding approvals of GM animals is unwise, is 
not in line with the EU‘s guiding precautionary principle and renders this exercise so flawed its results will be of 
questionable value. (p. 26) 
Also notably missing from the risk assessment considerations are ethical and moral issues surrounding genetic 
modification of animals. (p. 26) 
GM Freeze  
We do not believe that it is a sensible approach to compartmentalise issues of science , ethics, environmental 
impact, socio-economics and animal welfare because final decisions to approve (by politicians) or purchase (by 
farmers and consumers) should not be based solely on science and seldom are. No decisions about farming 
and food chain are ever based on science alone and never should be. (p. 40) 
Compassion in World Farming  
The summary says: “The question to be answered is whether there are problems in the health and welfare of 
GM animals”. Whilst this is an important question, it is not the fundamental ethical question, which is: “Should 
we genetically modify animals who are being reared for the production of food or feed?” Until this latter 
question has been answered – and answered in the affirmative – the statement referred to above is 
premature. (p. 24) 
(We) believe that the question we posed in the first paragraph … [Should we genetically modify animals for 
food and feed?] … should be referred urgently to the Ethical Group of Advisors in Science and New 
Technologies for an Opinion. (p. 24) 
Ministry of Rural Development of Hungary  
The social, ethical and religious considerations of introducing GM animals and animal products are missing 
from the risk assessment. (p. 17) 
American Anti-Vivisection Society  
A robust risk management process, one which includes ethical considerations, will also be necessary to protect 
animal interests and the public‘s interest in animal welfare. (p. 23) 
GeneWatch UK  
EFSA appears to want to begin at the point of assuming production is ethical and acceptable. This Guidance is 
premature until these important issues have been addressed. (p, 27) 
Animal Rights Sweden  
It is a great lack that the ethical aspects are not at all addressed in this guidance document. Ethical aspects are 
important and should not be excluded in discussing animal welfare and health. (p. 39) 
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A number of pressure groups have called for debate on the ethical and social issues for GM 
animals, for example, Friends of the Earth Europe, Test Biotech, Euro Coop, Eurogroup for 
Animals, European Milk Board and IFOAM EU Group (2012) submitted an ‘open letter’ to 
Commissioner Dalli raising concerns about the lack of public debate. Some of these NGOs 
and others took advantage of EFSA’s public consultations to submit comments that addressed 
ethical and social issues. It appears that the lack of opportunity for stakeholders and the 
public to debate the social and ethical issues elsewhere in the governance framework has led 
to increased frustration with EFSA’s public consultation and the risk assessment output per 
se.  
At this time, the governance framework for GM animals consists of EFSA’s risk assessment 
policy and is based solely on science. Brunk & Hartley (2012) have drawn attention to the 
risk to legitimacy that results from democratic mechanisms relying solely on science. These 
risks were also discussed at the EFSA workshop on animal cloning for food production where 
Gaskell et al (2007) note: “if risk managers do not recognize the import of ‘other factors’ then 
EFSA’s science based position may come into conflict with public perceptions... In such a 
situation trust in EFSA and other EU bodies may be jeopardised” (p. 5).   
4. Conclusion 
This policy process presents an important case for examining the tensions between the 
scientific and technical remit of public agency and the aims and expectations within the 
public consultation process. EFSA’s approach to public consultations acknowledges 
stakeholder and public knowledge as legitimate and recognises that this knowledge may 
improve the quality of risk assessment, but there are clear limitations to the way in which 
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EFSA operationalises governance commitments and policies. First, EFSA must operate 
within its statutory remit and therefore can only consult the public on the scientific aspects of 
risk assessment policy, although there is evidence that EFSA has blurred the lines of its remit 
by considering the social and ethical issues in other cases. Further, EFSA clearly limits the 
type of knowledge it accepts through its refusal to acknowledge value judgements in risk 
assessment. What might be seen as democratisation of expertise through the inclusion of the 
public in risk assessment, does not appear fit for purpose as it limits the type of knowledge 
which is deemed as acceptable to inform risk assessment and this appears out of step with 
public understandings of what should be considered in risk governance approaches.  
The European Commission’s Scientific Committees suggest that the tension between opening 
up risk assessment and managing the integrity of the scientific process could be handled 
through greater transparency (SCHER, 2013). However, our analysis of the case of risk 
assessment policy for GM animals suggests that as well as addressing transparency issues, 
creating a space for debating the broader risk management issues may be needed alongside 
the EFSA’s consultation. The EFSA public consultation policy tool presents a valuable and 
innovative opportunity to flush out the value judgements embedded in risk assessment and 
debate them in a way that can strengthen food safety governance. However, the public 
consultations on developing a risk assessment policy for GM animals appear to have drawn 
out some deep rooted frustrations with the boundaries set by EFSA and a lack of an 
alternative forum to debate the broader policy issues which could be said to fall under DG 
SANCO’s remit. Although EFSA’s Founding Regulation makes a clear distinction between 
scientific risk assessment and risk management, it also makes explicit the need for coherence 
between the three stages of risk analysis: assessment, management and communication. The 
Founding Regulation demands a strong relationship and close cooperation between risk 
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managers and EFSA to ensure this coherence (EC Regulation No 178, 2002). It would seem 
as though closer cooperation on public consultation is required to allow the public to provide 
input on the full range of issues related to risk governance of GM animals. Further work 
exploring the expectations and concerns of the key actors in this governance system should 
provide valuable data that could support future policy developments that strengthen and 
enhance, rather than reduce, this important institution’s legitimacy. 
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steps: hazard identification, hazard characterisation, exposure assessment and risk characterisation” (EC 
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choice of options and associated judgments for their application at appropriate decision points in the risk 
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deliberate release into the environment of genetically modified organisms and repealing Council Directive 
90/220/EEC and Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 
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food security was the focus of a U.S. Department of State Roundtable in 2013. In the EU, the majority of GM 
insects in agriculture are being developed for population suppression, containment and elimination, 
predominantly in the production of olives, tomatoes, citrus fruits, cabbages and cotton. The hope is that GM 
insects will improve existing population suppression, containment and elimination methods in agricultural 
production. Field trials for agricultural GM insects began in the United States in 2001, although an applications 
to release GM agricultural insects in Europe were made in Spain in 2013 and the UK in 2011 (in both cases 
more information was requested from the applicant about the risks. 
5 The Scientific /Technical Reports for EFSA’s environmental risk assessment policy for GM animals are: 1] 
Defining Environmental Risk Assessment Criteria for Genetically Modified Insects to be placed on the EU Market 
(Environment Agency Austria, 2010); 2] Defining Environmental Risk Assessment Criteria for Genetically 
Modified Fishes to be placed on the EU Market (University of Hull International Fisheries Institute, 2010); and 
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on the EU Market (Food and Environment Research Agency, 2011). 
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members of the Scientific Committee, Scientific Panels and external experts to assist EFSA with its scientific 
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